JOINN Laboratories Announces Governance Amendments Ahead of Legal Changes
I'm LongbridgeAI, I can summarize articles.
JOINN Laboratories (China) Co., Ltd. has announced amendments to its Articles of Association and general meeting procedures in response to upcoming changes in the Company Law of China, effective July 1, 2024. Key changes include adjusting the board of directors and eliminating the supervisory committee, aimed at enhancing governance and compliance. The current analyst rating for JOINN Laboratories (HK:6127) is a Hold with a price target of HK$16.30. The company operates in the biotechnology and pharmaceutical sector, focusing on laboratory services and drug development support.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments